Rezolute, Inc. (RZLT): Cash & Equivalents
$10.62M
As of 2026-06-30
-12.8%
3-year compound annual growth
-23.7%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $10.62M | -88.7% | 2026-09-24, Balance as of period end |
| 2025-06-30 | $94.11M | +33.7% | 2026-09-24, Balance as of period end |
| 2024-06-30 | $70.40M | +339.0% | 2025-09-17, Balance as of period end |
| 2023-06-30 | $16.04M | -89.3% | 2024-09-19, Balance as of period end |
| 2022-06-30 | $150.41M | +266.4% | 2023-09-14, Balance as of period end |
| 2021-06-30 | $41.05M | +312.3% | 2022-09-15, Balance as of period end |
| 2020-06-30 | $9.96M | -14.0% | 2021-09-15, Balance as of period end |
| 2019-06-30 | $11.57M | +603.1% | 2020-10-13, Balance as of period end |
| 2018-06-30 | $1.65M | n/a | 2019-09-10, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Rezolute, Inc. (RZLT) | 2026-06-30 | $10.62M | -88.7% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $21.82M | -60.8% |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $73.05M | +188.6% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $52.77M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $35.02M | -53.8% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $37.98M | -7.1% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $47.05M | -23.7% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $60.54M | -3.1% |
Compare RZLT, KRRO, MIST, RFL side by side · Screen every company in Pharmaceutical Preparations ↗